Parkinson Disease
Conditions
Keywords
Activities of Daily Living, Disease Management, Quality of Life, Rehabilitation, Patient-Centered Care, Delivery of Health Care, Integrated Care
Brief summary
The purpose of this study is to evaluate the efficacy of an online platform that allows neurologists and therapists to exchange therapy recommendations, communicate assessments and plan physical therapy, occupational therapy as well as speech and swallowing therapy for their patients.
Detailed description
The aim of this study is to enroll 185 patients in the intervention group and 185 patients in the control group. Patients in the intervention group come from the same region (Münsterland), the control group will consist of patients outside this region. The patients in the intervention group undergo therapies planned and coordinated through the online platform for 12 months. The patients in the intervention group will be evaluated using the PDQ-39, UPDRS, H&Y as well as Schwab & England. The patients in the control group will be evaluated using the PDQ-39.
Interventions
OTHERCoordination through the online platform JamesAKTIV
Coordination of the treatment through the online platform JamesAKTIV that allows neurologists and therapists to select specialised therapies for the predominant symptoms of the patients and communicate easily about problems during the treatment
Sponsors
privates Institut für angewandte Versorgungsforschung GmbH
AOK PLUS
University Hospital Muenster
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
No
Inclusion criteria
(Intervention Group): * Idiopathic Parkinson's Disease with pharmacological treatment * 30 years old or older * place of residence: Münsterland, Tecklenburger Land, Kreis and Stadt Osnabrück * sufficient knowledge of the German language, should be able to understand the consent form
Exclusion criteria
* severe cognitive deficits * Atypical Parkinsonian Disorders * participation in other studies
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Quality of Life measured by PDQ 39 | Change from Baseline PDQ 39 at 12 months | The Parkinson's Disease Questionnaire (PDQ-39, max. score of 100 indicates the worst quality of life) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Health-related resource use in the elderly population, assessed by FIMA | Change from Baseline FIMA at 12 months | FIMA stands for Questionnaire concerning Health-related resource use in the elderly population and is a German questionnaire assessing the Health-related resource use in the elderly population |
| Change in disease severity measured by UPDRS | Change from Baseline UPDRS at 12 months | UPDRS - Unified Parkinson's Disease Rating Scale, max. score of 199 points indicates the worst outcome |
| Change in disease severity measured by Hoehn & Yahr | Change from Baseline UPDRS at 12 months | Hoehn & Yahr is a simple scale that describes disease severity on a scale of 0-5, with 5 indicating severe disability |
| Change in mobility, measured by Schwab- & England-Scale | Change from Baseline Schwab-&England-Scale at 12 months | Schwab- & England-Scale assesses the capabilities of people with impaired mobility. The scale uses percentages with 100% indicating full independence. |
Countries
Germany
Contacts
Primary ContactTessa Huchtemann, Medical Degree
Backup ContactTobias Warnecke, Medical Degree, PhD
Outcome results
None listed